XENON PHARMACEUTICALS INC. (XENE) Total liabilities 2016–2025
XENON PHARMACEUTICALS INC. (XENE) total liabilities at each fiscal year-end, per SEC filings.
$51.4MFY2025 · since FY2016: $3.6M → $51.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $51.4M | +18.9% |
| FY2024 | $43.2M | +17.2% |
| FY2023 | $36.9M | +12.9% |
| FY2022 | $32.6M | +48.6% |
| FY2021 | $22.0M | +23.2% |
| FY2020 | $17.8M | -68.0% |
| FY2019 | $55.7M | — |
| FY2017 | $10.2M | +184.1% |
| FY2016 | $3.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice